萬順新材(300057.SZ):深圳宇鏘擬與鵬輝能源共同設立控股子公司 從事塗碳鋁箔等產品的加工和銷售
格隆匯8月8日丨萬順新材(300057.SZ)公佈,為滿足公司業務發展需要,完善塗碳鋁箔領域的市場佈局,公司全資子公司江蘇中基新能源科技集團有限公司下屬控股子公司深圳宇鏘新材料有限公司(簡稱“深圳宇鏘”)擬使用自有資金人民幣3000萬元與廣州鵬輝能源科技股份有限公司(簡稱“鵬輝能源”)共同投資設立控股子公司(名稱具體以工商登記註冊為準,以下簡稱“合資公司”)。該合資公司註冊資本人民幣5000萬元,其中深圳宇鏘認繳3000萬元,出資比例為60.00%,鵬輝能源認繳2000萬元,出資比例為40.00%,主要從事塗碳鋁箔等產品的加工和銷售。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.